Leukemia cutis: an indicator of relapse in a patient with myeloid leukemia – a case report
DOI:
https://doi.org/10.66344/jpad.14.4.2004.834Keywords:
Leukemia cutisAbstract
Leukemia cutis is a specific cutaneous lesion of leukemia in which there is deposition of
leukemic cells. We report an adult female with papulonodular lesions on the chest region. A
skin biopsy was found helpful in diagnosing the relapse in our patient with haematological
remission.
References
Ratram KV, Lkhor CJ, Danie l Su WP.
Leukemia cutis. Dermatol Clin 1994;
:419-31.
Zaman T, Pal SS, Khurshid K:
Leukemia cutis – the specific
cutaneous lesion of leukemia: a
clinical study of 250 patients. Ann
King Edward Medical College 1999;
: 255-8.
Buchner SA. Specific and nonspecific
skin manifestations in leukemia.
Schweiz Rundsch Med Prax 2002; 91:
-7.
Gambichler T, Herde M, Hoffmann
K. Poor prognosis of acute myeloid
leukaemia associated with leukaemia
cutis. J Eur Acad Dermatol Venereol
; 16: 177-8.
Bachmeyer C, Turc Y, Fraitag S.
Aleukemic monoblastic leukemia
cutis. Ann Dermatol Venereol 2003;
: 773-5.
Pont V, Miquel FJ, Grau TC. Skin
involvement in chronic
myelomonocytic leukaemia as a
predictor of transformation into acute
myeloid leukaemia. J Eur Acad
Dermatol Venereol 2001; 15: 260-2.
Ognbiyi AO, Shokunbi WA, Fasola
FA. Leukaemia cutis in a patient with
acute myelogenous leukaemia: case
report. East Afr Med J 2003; 80: 606-
Downloads
Published
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
